Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
Significant advances in hematopoietic transplantation over the past 20 years, have facilitated the safe transplantation of older adults with higher co-morbidities. In pediatric practice these advances have simultaneously improved outcomes for sicker children with complex, rare diseases including the...
Saved in:
Main Authors: | Emma C. Morris (Author), Michael H. Albert (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A rare case of hereditary spherocytosis treated with allogenic HSCT
by: Juhi Mehrotra, et al.
Published: (2022) -
RIC HSCT in primary immunodeficiency children in developing world - A ray of hope
by: Neha Rastogi, et al.
Published: (2016) -
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe
by: Alexei A. Grom, et al.
Published: (2024) -
HIV-specific T cells generated from HIV-naive adult and cord blood donors target a range of novel viral epitopes: implications for a cure strategy after allogeneic HSCT and CBT
by: S. Patel, et al.
Published: (2017) -
Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
by: Irina Zaidman, et al.
Published: (2023)